Provider

Guidehealth acquired Arcadia's managed services organization and value-based care services division. It also signed an agreement to leverage its data analytics platform.

Steven Ullman, the University of Miami's director at the Center for Health Management and Policy, discusses telehealth use during and following the pandemic, why patient and provider satisfaction varies, and policy predictions for 2024.  

The award will support veterans' access to the California-based virtual reality company's FDA-authorized at-home chronic low back pain offering, RelieVRx.

The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.

As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.  

The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.

Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.

At the HIMSS AI Conference in San Diego, panelists discussed the steps needed to strategically incorporate AI into the healthcare setting.

The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.